Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.
Ruggenenti P, Perico N, Gotti E, Cravedi P, D'Agati V, Gagliardini E, Abbate M, Gaspari F, Cattaneo D, Noris M, Casiraghi F, Todeschini M, Cugini D, Conti S, Remuzzi G. Ruggenenti P, et al. Among authors: gotti e. Transplantation. 2007 Oct 27;84(8):956-64. doi: 10.1097/01.tp.0000284808.28353.2c. Transplantation. 2007. PMID: 17989600 Clinical Trial.
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial.
Perico N, Ruggenenti P, Gotti E, Gaspari F, Cattaneo D, Valente U, Salvadori M, Segoloni G, Donati D, Sandrini S, Ganeva M, Dimitrov BD, Remuzzi G; MY.S.S. Study Investigators. Perico N, et al. Among authors: gotti e. Kidney Int. 2004 Mar;65(3):1084-90. doi: 10.1111/j.1523-1755.2004.00471.x. Kidney Int. 2004. PMID: 14871429 Free article. Clinical Trial.
Regulatory T cells and T cell depletion: role of immunosuppressive drugs.
Noris M, Casiraghi F, Todeschini M, Cravedi P, Cugini D, Monteferrante G, Aiello S, Cassis L, Gotti E, Gaspari F, Cattaneo D, Perico N, Remuzzi G. Noris M, et al. Among authors: gotti e. J Am Soc Nephrol. 2007 Mar;18(3):1007-18. doi: 10.1681/ASN.2006101143. Epub 2007 Feb 7. J Am Soc Nephrol. 2007. PMID: 17287424
Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.
Perico N, Casiraghi F, Gotti E, Introna M, Todeschini M, Cavinato RA, Capelli C, Rambaldi A, Cassis P, Rizzo P, Cortinovis M, Noris M, Remuzzi G. Perico N, et al. Among authors: gotti e. Transpl Int. 2013 Sep;26(9):867-78. doi: 10.1111/tri.12132. Epub 2013 Jun 6. Transpl Int. 2013. PMID: 23738760 Free article. Clinical Trial.
In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.
Todeschini M, Cortinovis M, Perico N, Poli F, Innocente A, Cavinato RA, Gotti E, Ruggenenti P, Gaspari F, Noris M, Remuzzi G, Casiraghi F. Todeschini M, et al. Among authors: gotti e. J Immunol. 2013 Sep 1;191(5):2818-28. doi: 10.4049/jimmunol.1203261. Epub 2013 Aug 2. J Immunol. 2013. PMID: 23913968 Clinical Trial.
119 results